These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1279896)

  • 21. Infectivity-enhancing antibodies to Ebola virus glycoprotein.
    Takada A; Watanabe S; Okazaki K; Kida H; Kawaoka Y
    J Virol; 2001 Mar; 75(5):2324-30. PubMed ID: 11160735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of an immunofluorescence focus assay for Ebola virus.
    Truant AL; Regnery RL; Kiley MP
    J Clin Microbiol; 1983 Aug; 18(2):416-9. PubMed ID: 6352735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of cross reactivity of rhabdovirus antibodies with Marburg and Ebola antigens in the indirect immunofluorescent antibody test.
    Van der Groen G; Elliot LH
    Ann Soc Belg Med Trop; 1982 Mar; 62(1):67-8. PubMed ID: 6179483
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
    Geisbert TW; Hensley LE; Geisbert JB; Jahrling PB
    Virology; 2002 Feb; 293(1):15-9. PubMed ID: 11853394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic analysis of strains of Ebola virus: identification of two Ebola virus serotypes.
    Richman DD; Cleveland PH; McCormick JB; Johnson KM
    J Infect Dis; 1983 Feb; 147(2):268-71. PubMed ID: 6827143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.
    Boehmann Y; Enterlein S; Randolf A; Mühlberger E
    Virology; 2005 Feb; 332(1):406-17. PubMed ID: 15661171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arenaviruses: cellular response to long-term in vitro infection with parana and lymphocytic choriomeningitis viruses.
    Staneck LD; Trowbridge RS; Welsh RM; Wright EA; Pfau CJ
    Infect Immun; 1972 Oct; 6(4):444-50. PubMed ID: 4564281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of the multiplication, in cell cultures, of 2 strains of parainfluenza virus of type 3. I. Multiplication in KB cell line].
    Isaia G; Teodosiu O; Broniţki A; Moisa I
    Stud Cercet Virusol; 1972; 23(2):123-33. PubMed ID: 4345826
    [No Abstract]   [Full Text] [Related]  

  • 29. Replication of infectious bursal disease virus in continuous cell lines.
    Jackwood DH; Saif YM; Hughes JH
    Avian Dis; 1987; 31(2):370-5. PubMed ID: 3039967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers].
    Ivanov AP; Tkachenko EA; van der Groen G; Butenko AM; Konstantinov OK
    Vopr Virusol; 1986; 31(2):186-90. PubMed ID: 3524001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication and plaque formation of swine hemagglutinating encephalomyelitis virus (67N) in swine cell line, SK-K culture.
    Hirano N; Ono K; Takasawa H; Murakami T; Haga S
    J Virol Methods; 1990 Jan; 27(1):91-100. PubMed ID: 2407748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent infection of BHK cells with herpes simplex virus types 1 and 2 in the absence of specific anti-herpetic antibody.
    Szántó J; Lesso J; Lackovic V
    Acta Virol; 1976 Feb; 20(1):40-7. PubMed ID: 7939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
    Volchkov VE; Volchkova VA; Muhlberger E; Kolesnikova LV; Weik M; Dolnik O; Klenk HD
    Science; 2001 Mar; 291(5510):1965-9. PubMed ID: 11239157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and assay of rabies serogroup viruses in CER cells.
    Smith AL; Tignor GH; Mifune K; Motohashi T
    Intervirology; 1977; 8(2):92-9. PubMed ID: 67104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
    Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
    J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plaque assay for Ebola virus.
    Moe JB; Lambert RD; Lupton HW
    J Clin Microbiol; 1981 Apr; 13(4):791-3. PubMed ID: 7014628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication of avian infectious bronchitis virus in African green monkey kidney cell line VERO.
    Cunningham CH; Spring MP; Nazerian K
    J Gen Virol; 1972 Sep; 16(3):423-7. PubMed ID: 4627930
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective efficacy of neutralizing antibodies against Ebola virus infection.
    Takada A; Ebihara H; Jones S; Feldmann H; Kawaoka Y
    Vaccine; 2007 Jan; 25(6):993-9. PubMed ID: 17055127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.
    Grolla A; Lucht A; Dick D; Strong JE; Feldmann H
    Bull Soc Pathol Exot; 2005 Sep; 98(3):205-9. PubMed ID: 16267962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional and enhanced plaque neutralization assay for polio antibody.
    Boone EJ; Albrecht P
    J Virol Methods; 1983 Apr; 6(4):193-202. PubMed ID: 6306035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.